These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31025167)

  • 1. Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy.
    Joukar F; Mavaddati S; Mansour-Ghanaei F; Samadani AA
    J Gastrointest Cancer; 2020 Jun; 51(2):363-378. PubMed ID: 31025167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of microbiota in cancer therapy.
    Perez-Chanona E; Trinchieri G
    Curr Opin Immunol; 2016 Apr; 39():75-81. PubMed ID: 26820225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tumor Microbiome in Pancreatic Cancer: Bacteria and Beyond.
    McAllister F; Khan MAW; Helmink B; Wargo JA
    Cancer Cell; 2019 Dec; 36(6):577-579. PubMed ID: 31951558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle alters GUT-bacteria function: Linking immune response and host.
    Jazayeri O; Daghighi SM; Rezaee F
    Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):625-635. PubMed ID: 29566905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome, inflammation and colorectal cancer.
    Chen J; Pitmon E; Wang K
    Semin Immunol; 2017 Aug; 32():43-53. PubMed ID: 28982615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microbiome and cancer for clinicians.
    Picardo SL; Coburn B; Hansen AR
    Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.
    Gately S
    Cancer Treat Res; 2019; 178():253-264. PubMed ID: 31209849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
    Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
    Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities.
    Pandey P; Khan F
    Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130401. PubMed ID: 37307905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut microbiome and melanoma: A review.
    Makaranka S; Scutt F; Frixou M; Wensley KE; Sharma R; Greenhowe J
    Exp Dermatol; 2022 Sep; 31(9):1292-1301. PubMed ID: 35793428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses.
    Jaye K; Li CG; Bhuyan DJ
    Crit Rev Oncol Hematol; 2021 Sep; 165():103429. PubMed ID: 34293459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome and cancer treatment: Are we ready to apply in clinics?
    Chan SL
    Prog Mol Biol Transl Sci; 2020; 171():301-308. PubMed ID: 32475526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Role of Gut Microbiota in Lung Carcinogenesis and Cancer Immunotherapy].
    Shoji F
    Gan To Kagaku Ryoho; 2024 Jun; 51(6):597-602. PubMed ID: 39009513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action.
    Tao J; Li S; Gan RY; Zhao CN; Meng X; Li HB
    Crit Rev Food Sci Nutr; 2020; 60(6):1025-1037. PubMed ID: 30632784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Formation of Glycan-Specific Natural Antibodies Repertoire in GalT-KO Mice Is Determined by Gut Microbiota.
    Bello-Gil D; Audebert C; Olivera-Ardid S; Pérez-Cruz M; Even G; Khasbiullina N; Gantois N; Shilova N; Merlin S; Costa C; Bovin N; Mañez R
    Front Immunol; 2019; 10():342. PubMed ID: 30891034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy.
    Zhu R; Lang T; Yan W; Zhu X; Huang X; Yin Q; Li Y
    Adv Sci (Weinh); 2021 May; 8(10):2003542. PubMed ID: 34026439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
    Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
    Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.